Ronda Stryker, the director of Stryker, sold 12,000 shares of the business's stock last Friday for $1,354,200, The Cerbat Gem reports. Here's what you need to know.
1. Ms. Stryker still owns 193,142 shares of the company's stock at an estimated value of $21,796,074.70.
2. Stryker opened at $114.32 on Friday. It has a market cap of $42.79 billion and a price-to-earnings ratio of $26.95. Its 50 day moving average is at $114.46 and its 200 day is at $112.46.
3. Its last quarterly earnings were posted in July, where it beat Thomson Reuters' estimate of $1.37 by $.02.
4. Stryker earned $2.84 billion during that quarter, which was higher than the $2.79 billion estimated.
More orthopedic device news:
Medtronic's Hybrid Closed Loop system sees positive pivotal trial results: 6 observations
Alphatec shifts leadership roles; updates compliance with Nasdaq listing: 7 highlights
Zimmer Biomet, NuVasive, Implanet & more: 8 key notes